The UK's R&D budget for health and medical sciences is forecasted to maintain a consistent value of 0.13% of GDP from 2024 through 2028, reflecting a stabilization in government investment after previous fluctuations. In 2023, the actual spending level also stood at 0.13% of GDP, underscoring a neutral year-on-year growth rate and indicating a flat CAGR over the preceding five years.

Future trends to watch for include:

Policy shifts that could alter funding allocations, potentially increasing R&D investment if health and medical innovation becomes a strategic priority.
Economic changes impacting GDP, which may alter the relative share of R&D spending.
Technological advancements and emerging health challenges that could spur increased demand for R&D funding in this sector.